From: Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
Compounds
IC50 values against total HDAC activity (nM)
MAKV-6
1050 ± 220
MAKV-7
22,000 ± 25,200
MAKV-8
5.8 ± 3.8
MAKV-10
> 100,000
MAKV-12